RxDoctor Payments Data

Taylor Smith, PA

Physician Assistant · Idaho Falls, IDNPI 1912548421

Payments from drug & device makers

$343in general payments, 2019–2025

Across 9 payments — averaging $38.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$136
  • Sumitomo Pharma America, Inc.$84
  • Myovant Sciences Inc.$58
  • Johnson & Johnson$21
  • Hologic Sales And Service, LLC$16
  • AbbVie$15
  • plus $14 from 1 others
$1,862in research payments, 2019–2025

Across 11 payments — averaging $169.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi Pasteur Inc.$2K

What the payments were for

  • Food & beverage$31191%
  • Education$329%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$343 in reported general payments places this provider in the 50th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$8,023
Medicare patients
57
Services billed
130

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide21$19,788
ProgesteroneProgesterone, Micronized67$4,536
Testosterone Cypionate27$1,909
Np ThyroidThyroid,pork20$1,390
SynthroidLevothyroxine Sodium14$850
Levothyroxine Sodium65$445
Duloxetine Hcl13$317
Bupropion XlBupropion Hcl11$182
Venlafaxine Hcl ErVenlafaxine Hcl11$117
Spironolactone13$94
Lisinopril26$90
Escitalopram Oxalate20$85
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide32$45
Metformin Hcl22$26
Losartan Potassium15$26

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$136$19,78821 claims
AbbVieSynthroid$15$85014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →